These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 8597531)

  • 1. Liver regeneration and hepatocarcinogenesis in transforming growth factor-alpha-targeted mice.
    Russell WE; Kaufmann WK; Sitaric S; Luetteke NC; Lee DC
    Mol Carcinog; 1996 Mar; 15(3):183-9. PubMed ID: 8597531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced hepatocyte proliferation is the basis of retarded liver tumor progression and liver regeneration in mice lacking N-acetylglucosaminyltransferase III.
    Yang X; Tang J; Rogler CE; Stanley P
    Cancer Res; 2003 Nov; 63(22):7753-9. PubMed ID: 14633700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Collaboration between growth factors and diverse chemical carcinogens in hepatocarcinogenesis of transforming growth factor alpha transgenic mice.
    Takagi H; Sharp R; Takayama H; Anver MR; Ward JM; Merlino G
    Cancer Res; 1993 Sep; 53(18):4329-36. PubMed ID: 8364928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid development of hepatic tumors in transforming growth factor alpha transgenic mice associated with increased cell proliferation in precancerous hepatocellular lesions initiated by N-nitrosodiethylamine and promoted by phenobarbital.
    Tamano S; Merlino GT; Ward JM
    Carcinogenesis; 1994 Sep; 15(9):1791-8. PubMed ID: 7923571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ectopic activity of fibroblast growth factor receptor 1 in hepatocytes accelerates hepatocarcinogenesis by driving proliferation and vascular endothelial growth factor-induced angiogenesis.
    Huang X; Yu C; Jin C; Kobayashi M; Bowles CA; Wang F; McKeehan WL
    Cancer Res; 2006 Feb; 66(3):1481-90. PubMed ID: 16452204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolution of neoplastic development in the liver of transgenic mice co-expressing c-myc and transforming growth factor-alpha.
    Santoni-Rugiu E; Nagy P; Jensen MR; Factor VM; Thorgeirsson SS
    Am J Pathol; 1996 Aug; 149(2):407-28. PubMed ID: 8701981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bcl-2 delays and alters hepatic carcinogenesis induced by transforming growth factor alpha.
    Vail ME; Pierce RH; Fausto N
    Cancer Res; 2001 Jan; 61(2):594-601. PubMed ID: 11212255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coexpression of C-myc and transforming growth factor alfa in the liver promotes early replicative senescence and diminishes regenerative capacity after partial hepatectomy in transgenic mice.
    Factor VM; Jensen MR; Thorgeirsson SS
    Hepatology; 1997 Dec; 26(6):1434-43. PubMed ID: 9397983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of phenobarbital-mediated promotion of hepatocarcinogenesis in connexin32-null mice.
    Moennikes O; Buchmann A; Romualdi A; Ott T; Werringloer J; Willecke K; Schwarz M
    Cancer Res; 2000 Sep; 60(18):5087-91. PubMed ID: 11016633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transgenic disruption of gap junctional intercellular communication enhances early but not late stage hepatocarcinogenesis in the rat.
    Hokaiwado N; Asamoto M; Ogawa K; Shirai T
    Toxicol Pathol; 2005; 33(6):695-701. PubMed ID: 16243774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transforming growth factor-alpha in carcinogen-induced F344 rat hepatic foci.
    Steinmetz KL; Klaunig JE
    Toxicol Appl Pharmacol; 1996 Sep; 140(1):131-45. PubMed ID: 8806879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming growth factor-alpha expression in rat experimental hepatocarcinogenesis.
    Pérez-Tomás R; Mayol X; Culleré X; Díaz Ruiz C; Domingo J
    Histol Histopathol; 1992 Jul; 7(3):457-62. PubMed ID: 1504466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative relationship between transforming growth factor-alpha and hepatic focal phenotype and progression in female mouse liver.
    Moser GJ; Wolf DC; Goldsworthy TL
    Toxicol Pathol; 1997; 25(3):275-83. PubMed ID: 9210259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum transforming growth factor-alpha level can be a parameter for evaluating liver regeneration after partial hepatectomy in patients with liver cancer.
    Tomiya T; Hayashi S; Yanase M; Umeda N; Tani M; Yamada S; Masaki N; Ogata I; Fujiwara K
    Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-14-S6-17. PubMed ID: 9151911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Normal liver regeneration and liver cell apoptosis after partial hepatectomy in tumor necrosis factor-alpha-deficient mice.
    Hayashi H; Nagaki M; Imose M; Osawa Y; Kimura K; Takai S; Imao M; Naiki T; Kato T; Moriwaki H
    Liver Int; 2005 Feb; 25(1):162-70. PubMed ID: 15698414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Constitutive expression of mature transforming growth factor beta1 in the liver accelerates hepatocarcinogenesis in transgenic mice.
    Factor VM; Kao CY; Santoni-Rugiu E; Woitach JT; Jensen MR; Thorgeirsson SS
    Cancer Res; 1997 Jun; 57(11):2089-95. PubMed ID: 9187100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression analysis on the dicyclanil-induced hepatocellular tumors in mice.
    Moto M; Okamura M; Muguruma M; Ito T; Jin M; Kashida Y; Mitsumori K
    Toxicol Pathol; 2006; 34(6):744-51. PubMed ID: 17162532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apoptosis in stages of mouse hepatocarcinogenesis: failure to counterbalance cell proliferation and to account for strain differences in tumor susceptibility.
    Bursch W; Chabicovsky M; Wastl U; Grasl-Kraupp B; Bukowska K; Taper H; Schulte-Hermann R
    Toxicol Sci; 2005 May; 85(1):515-29. PubMed ID: 15728704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular and genetic analysis of liver oncogenesis in transforming growth factor alpha transgenic mice.
    Takagi H; Sharp R; Hammermeister C; Goodrow T; Bradley MO; Fausto N; Merlino G
    Cancer Res; 1992 Oct; 52(19):5171-7. PubMed ID: 1394122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming growth factor-alpha expression is altered during experimental hepatocarcinogenesis.
    Burr AW; Toole K; Mathew J; Hines JE; Chapman C; Burt AD
    J Pathol; 1996 Jul; 179(3):276-82. PubMed ID: 8774483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.